Latest Continuous Disclosure News

Page 32 of 55
Yandal Resources has clarified that a recent spike in its share price follows a significant off-market block trade, with no undisclosed material information influencing the market. The company also signals imminent drilling activity at its Ironstone Well-Barwidgee Gold Project.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Nexion Group Ltd has reported a significantly reduced net loss for FY25, driven by major asset sales and a strategic pivot towards AI and business intelligence. The company’s divestments are expected to strengthen its balance sheet and provide steady cash inflows.
Victor Sage
Victor Sage
29 Aug 2025
Enterprise Metals Limited has addressed recent sharp price and volume movements in its shares, attributing the activity to upcoming drilling programs and positive market sentiment in rare earth elements and critical minerals.
Maxwell Dee
Maxwell Dee
29 Aug 2025
The Star Entertainment Group reported a $471.5 million net loss for FY25, marking a 72% improvement from the prior year but underscored by ongoing regulatory challenges and a complex joint venture exit.
Victor Sage
Victor Sage
29 Aug 2025
Bentley Capital Limited reported a reduced net loss of $878,418 for FY25, driven by unrealised investment losses primarily linked to its significant stake in Strike Resources. The company continues to navigate market volatility and operational hurdles with strategic cost controls and asset sales.
Claire Turing
Claire Turing
28 Aug 2025
DigiCo Infrastructure REIT confirms its FY25 EBITDA slightly exceeded IPO guidance and aligned with analyst forecasts, attributing recent share price declines to the absence of FY26 earnings guidance.
Victor Sage
Victor Sage
28 Aug 2025
Helix Resources Limited’s HLXOA securities have been suspended from trading pending regulatory compliance, raising questions about the company’s immediate outlook.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Invion Limited has affirmed its compliance with ASX disclosure rules following the US FDA’s granting of Orphan Drug Designation for its anal cancer treatment candidate INV043. The company detailed the timing and verification process behind its announcement.
Ada Torres
Ada Torres
28 Aug 2025
James Hardie Industries confirms its Q1 FY26 earnings met market expectations despite a challenging North American housing market, while revising its FY26 guidance following the AZEK acquisition.
Victor Sage
Victor Sage
27 Aug 2025
Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.
Claire Turing
Claire Turing
27 Aug 2025
Kaili Resources has responded to ASX inquiries following volatile trading, confirming imminent rare earth element drilling in South Australia and revealing detailed shareholder data.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Kaili Resources has responded to an ASX price query following a dramatic rise in its share price, denying any undisclosed material information and confirming full compliance with ASX listing rules.
Maxwell Dee
Maxwell Dee
26 Aug 2025